Skip to content Skip to navigation

26th Annual Biomedical Distinguished Lecture Series Presents Jonathan Brody, Ph.D.: "Why is Pancreatic Cancer the Most Difficult Cancer to Treat, Yet We Know So Much About It?"

26th Annual Biomedical Distinguished Lecture Series Presents Jonathan Brody, Ph.D.: "Why is Pancreatic Cancer the Most Difficult Cancer to Treat, Yet We Know So Much About It?"

April 10, 2019 - 2:00pm
Location: 
East Parlor, St. Joseph Hall, Chestnut Hill College

Celebrating the 26th Annual Biomedical Distinguished Lecture Series

Chestnut Hill College and the Center for Natural and Behavioral Sciences (formerly the Department of Biology/Division of Natural Sciences) presents Jonathan Brody, Ph.D.

Dr. Jonathan Brody is currently the Director of Surgical Research and Co-director of the Jefferson Pancreatic, Billary, and Related Cancer Center. He is also a member of the Kimmel Cancer Center (with a leadership role in GI Program) and a professor within the departments of Surgery and Pathology. Dr. Brody received his Ph.D. from The Johns Hopkins University School of Medicine and his thesis specialized in studying the molecular aspects of cancer and cancer genetics. He patented, with Dr. Scott Kern, novel buffers for DNA identification that have changed the format of this molecular biology technique used to detect DNA. He was elected Chair of the Cancer Research Program, Department of Defense Council and serves on many international study sections including currently being the Chair of the Tumor Biology and Genomics study section for the American Cancer Society and NCI study section panels. He has published over 100 peer review publications in many top tier scientific and cancer journals. Additionally, he was an American Cancer Society Research Scholar, is NIH funded, and won the American Association of Cancer Research, Pancreatic Cancer Career Development Award in 2010. His lab focuses on the many molecular aspects of pancreatic cancer, including developing ways to target a novel pro-survival network in pancreatic cancer cells and optimizing current therapies used in the clinic. He also has an interest in personalizing therapy for pancreatic cancer patients.

This event is free and open to the public. It is also a passport event for first-year students. Please contact, Dr. Lakshmi Atchison, Professor of Biology and Director of the Biomedical Distinguished Lecture Series (215-248-7159) or email: latchiso@chc.edu for more information.

Open/Applies to: 
Public
Alumni
Prospective Students
All Current Students
Faculty
Staff
Posted In: Academic Events